Andrew Jan

Andrew Jan is an accomplished professional with extensive experience in clinical quality assurance and good clinical practice (GCP) oversight. Currently serving as Associate Director of GCP/Clinical Quality at REVOLUTION Medicines, Andrew has previously held key roles at Independent Consulting as a QA Consultant, and at Nuvation Bio as Associate Director of Clinical Quality Assurance. Andrew's career also includes a position as Senior Manager of QA and Validation at the Parker Institute for Cancer Immunotherapy, and Manager of GCP QA at Bolt Biotherapeutics, Inc., demonstrating a strong background in managing quality assurance processes within the biopharmaceutical sector.